scholarly article | Q13442814 |
P50 | author | Vittorio Colizzi | Q3561362 |
Francesca Spadaro | Q39569572 | ||
Silvia Vendetti | Q45286671 | ||
Antonio Ciaramella | Q48965539 | ||
Alessandra Sacchi | Q55465264 | ||
P2093 | author name string | Carlo Ramoni | |
Leopoldo Paolo Pucillo | |||
Angelo Martino | |||
Nunzia Sanarico | |||
P2860 | cites work | Dendritic cells and the control of immunity | Q27860918 |
Has BCG attenuated to impotence? | Q59098588 | ||
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection | Q28378014 | ||
Immunobiology of dendritic cells | Q29547465 | ||
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection | Q29616521 | ||
Live antigen carriers as tools for improved anti-tuberculosis vaccines | Q33541149 | ||
Characterization of murine lung dendritic cells infected with Mycobacterium tuberculosis | Q34006092 | ||
The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics | Q34282306 | ||
Variation in protection by BCG: implications of and for heterologous immunity | Q34288541 | ||
Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis | Q34338450 | ||
Regulation of T cell immunity by dendritic cells | Q34339191 | ||
Dendritic cells as vectors for therapy | Q34339199 | ||
Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency | Q34469625 | ||
How dendritic cells and microbes interact to elicit or subvert protective immune responses | Q34712641 | ||
A novel TB vaccine; towards a strategy based on our understanding of BCG failure. | Q35005145 | ||
CD1b-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection | Q36368972 | ||
Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells | Q36369072 | ||
CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells | Q37698653 | ||
IL-6 switches the differentiation of monocytes from dendritic cells to macrophages | Q40819435 | ||
Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice | Q40894562 | ||
Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor | Q43628970 | ||
Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response | Q44178645 | ||
Gangliosides from human melanoma tumors impair dendritic cell differentiation from monocytes and induce their apoptosis | Q44368619 | ||
BCG promotes cord blood monocyte-derived dendritic cell maturation with nuclear Rel-B up-regulation and cytosolic I kappa B alpha and beta degradation. | Q44388759 | ||
Differentiation of human dendritic cells from monocytes in vitro. | Q51106538 | ||
Intersection of group I CD1 molecules and mycobacteria in different intracellular compartments of dendritic cells. | Q52972567 | ||
P433 | issue | 4 | |
P921 | main subject | dendritic cell | Q506253 |
P304 | page(s) | 827-834 | |
P577 | publication date | 2004-07-07 | |
P1433 | published in | Journal of Leukocyte Biology | Q1524048 |
P1476 | title | Dendritic cells derived from BCG-infected precursors induce Th2-like immune response | |
P478 | volume | 76 |
Q37199216 | A novel recombinant DNA vaccine encoding Mycobacterium tuberculosis ESAT-6 and FL protects against Mycobacterium tuberculosis challenge in mice |
Q44903966 | BCG stimulated dendritic cells induce an interleukin-10 producing T-cell population with no T helper 1 or T helper 2 bias in vitro |
Q34739851 | Cholera toxin impairs the differentiation of monocytes into dendritic cells, inducing professional antigen-presenting myeloid cells |
Q35689204 | Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development |
Q33631222 | Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model. |
Q42258029 | Effects of some natural immunomodulatory compounds in combination with thalidomide on survival rate and tumor size in fibrosarcoma-bearing mice. |
Q44653216 | Enhancement of BCG-induced Th1 immune response through Vgamma9Vdelta2 T cell activation with non-peptidic drugs |
Q33750869 | Human monocytes respond to extracellular cAMP through A2A and A2B adenosine receptors |
Q37737607 | Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis? |
Q36213975 | Immune responses to tuberculosis in developing countries: implications for new vaccines |
Q83106222 | Influence of pertussis toxin on CD1a isoform expression in human dendritic cells |
Q54621900 | Interleukin-4 can induce interleukin-4 production in dendritic cells. |
Q37592378 | Lipidated promiscuous peptide augments the expression of MHC-II molecules on dendritic cells and activates T cells |
Q37122974 | Mycobacteria and innate cells: critical encounter for immunogenicity |
Q34241776 | Mycobacterium bovis BCG promotes tumor cell survival from tumor necrosis factor-α-induced apoptosis |
Q56899626 | Mycobacterium bovis bacillus Calmette-Guerin treated human cord blood monocyte-derived dendritic cells polarize naïve T cells into a tolerogenic phenotype in newborns |
Q37082976 | Neonatal Bacillus Calmette-Guérin vaccination alleviates lipopolysaccharide-induced neurobehavioral impairments and neuroinflammation in adult mice |
Q57235905 | Non-Pathogenic Mycobacterium smegmatis Induces the Differentiation of Human Monocytes Directly into Fully Mature Dendritic Cells |
Q55060473 | Prime-boost BCG vaccination with DNA vaccines based in β-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model. |
Q36978792 | Sphingosine 1-phosphate as a novel immune regulator of dendritic cells |
Q31140592 | The 30-kDa and 38-kDa antigens from Mycobacterium tuberculosis induce partial maturation of human dendritic cells shifting CD4(+) T cell responses towards IL-4 production |
Q37652470 | The role of dendritic cells in mycobacterium-induced granulomas |
Q43043113 | The ΔfbpA attenuated candidate vaccine from Mycobacterium tuberculosis, H37Rv primes for a stronger T-bet dependent Th1 immunity in mice |
Search more.